Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
Senores Pharmaceuticals Limited (SENORES) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The SENORES share price is ₹1,175.00 (+1.21% today), with a market capitalisation of ₹54B and a price-to-earnings (P/E) ratio of 38.6. MarketRipple tracks the SENORES investment thesis, the ripple-chain impact of market events on Senores Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹1,199.00
High
₹1,219.70
Low
₹1,170.00
Prev. Close
₹1,161.00
52W High
₹1,599.00
52W Low
₹706.00
Day range
₹1,170.00–₹1,219.70
52-week range
₹706.00–₹1,599.00
Volume
155K
P/E
38.6
ROE
14.7%
D/E
0.37
Margin
18.6%
Senores Pharmaceuticals Limited (NSE: SENORES) is currently trading at ₹1,175.00 (+1.21%).
Senores Pharmaceuticals Limited's market capitalization is ₹54B.
Senores Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 38.6.
Senores Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - General).
Analyst consensus on Senores Pharmaceuticals Limited currently reads strongly positive, based on 5 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.